Tscan Therapeutics logo

Tscan Therapeutics Share Price Today

(NASDAQ: TCRX)

Tscan Therapeutics share price is $1.92 & ₹166.98 as on 6 Mar 2025, 2.30 'hrs' IST

$1.92

-0.1

(-4.95%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Tscan Therapeutics share price in Dollar and Rupees. Guide to invest in Tscan Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Tscan Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Tscan Therapeutics share price movements

  • Today's Low: $1.88
    Today's High: $2.04

    Day's Volatility :8.09%

  • 52 Weeks Low: $1.84
    52 Weeks High: $9.69

    52 Weeks Volatility :81.01%

Tscan Therapeutics (TCRX) Returns

PeriodTscan Therapeutics IncIndex (Russel 2000)
3 Months
-52.02%
0.0%
6 Months
-64.12%
0.0%
1 Year
-71.75%
0.0%
3 Years
-46.42%
-11.6%

Tscan Therapeutics (TCRX) Key Statistics

in dollars & INR

Previous Close
$2.02
Open
$2.04
Today's High
$2.04
Today's Low
$1.875
Market Capitalization
$104.3M
Today's Volume
$64.7K
52 Week High
$9.69
52 Week Low
$1.84
Revenue TTM
$9.4M
EBITDA
$-114.8M
Earnings Per Share (EPS)
$-0.95
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-55.92%

How to invest in Tscan Therapeutics Stock (TCRX) from India?

It is very easy for Indian residents to invest directly in Tscan Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Tscan Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Tscan Therapeutics or TCRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Tscan Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Tscan Therapeutics shares which would translate to 0.453 fractional shares of Tscan Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Tscan Therapeutics, in just a few clicks!

Returns in Tscan Therapeutics (TCRX) for Indian investors in Rupees

The Tscan Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tscan Therapeutics investment value today

Current value as on today

₹31,816

Returns

₹68,184

(-68.18%)

Returns from Tscan Therapeutics Stock

₹73,147 (-73.15%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Tscan Therapeutics (TCRX)

-63%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Tscan Therapeutics Stock from India on INDmoney has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Tscan Therapeutics

  • EcoR1 Capital, LLC

    8.85%

  • BlackRock Inc

    8.78%

  • Adage Capital Partners Gp LLC

    6.19%

  • Bvf Inc

    5.29%

  • Baker Bros Advisors LP

    4.93%

  • Vanguard Group Inc

    4.22%

Analyst Recommendation on Tscan Therapeutics

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Tscan Therapeutics(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Tscan Therapeutics Stock (TCRX)

What analysts predicted

Upside of 532.44%

Target:

$12.14

Current:

$1.92

Insights on Tscan Therapeutics Stock (Ticker Symbol: TCRX)

  • Price Movement

    In the last 7 days, TCRX stock has moved up by 5.8%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 536.0K → 1.04M (in $), with an average increase of 48.9% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -31.66M → -29.88M (in $), with an average increase of 5.9% per quarter
  • TCRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 133.6%
  • TCRX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 94.4%
  • Price to Sales

    ForTCRX every $1 of sales, investors are willing to pay $11.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Tscan Therapeutics Technicals Summary

Sell

Neutral

Buy

Tscan Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Tscan Therapeutics (TCRX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Tscan Therapeutics Inc logo
-16.87%
-64.12%
-71.75%
-46.42%
-80.76%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Tscan Therapeutics Inc logo
NA
NA
NA
-1.12
-0.56
-0.23
NA
4.29
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Tscan Therapeutics Inc logo
Buy
$104.3M
-80.76%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Tscan Therapeutics

TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product candidates include TSC-100 and TSC-101 that is in Phase I clinical trial for the treatment of patients with hematologic malignancies to eliminate residual disease and prevent relapse after allogeneic hematopoietic cell transplantation. It also develops TSC-200, TSC-201, TSC-203, and TSC-204, which are in Phase 1 clinical trial, for the treatment of solid tumors; and TSC-202 to treat solid tumors. In addition, the company develops vaccines for infectious diseases, such as SARS-CoV-2. It has collaborations with Novartis Institutes for BioMedical Research, Inc. To discover and develop novel TCR-T therapies; and Amgen Inc. to identify antigens recognized by T cells in patients with Crohn's disease using TargetScan, a proprietary target discovery platform. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
Organization
Tscan Therapeutics
Employees
188
CEO
Dr. Gavin MacBeath Ph.D.
Industry
Miscellaneous

Management People of Tscan Therapeutics

NameTitle
Dr. Gavin MacBeath Ph.D.
CEO & Director
Dr. Zoran Zdraveski J.D., Ph.D.
Chief Legal & Strategy Officer and Company Secretary
Dr. Stephen J. Elledge Ph.D.
Co-Founder & Chairman of Scientific Advisory Board
Mr. Tomasz Kula Ph.D.
Co-Founder & Member of Advisory Board
Mr. Jason A. Amello CPA
CFO & Treasurer
Dr. Justin McCue Ph.D.
Chief Technology Officer
Ms. Ann Hargraves
Senior Vice President of Human Resources
Dr. Shrikanta Chattopadhyay M.D.
Senior VP & Head of Translational Medicine
Mr. Ray Lockard M.B.A.
Senior Vice President & Head of Quality
Mr. Jim Murray
Senior VP & Head of Development Operations

Important FAQs about investing in TCRX Stock from India :

What is Tscan Therapeutics share price today?

Tscan Therapeutics share price today stands at $1.92, Open: $2.04 ; Previous Close: $2.02 ; High: $2.04 ; Low: $1.88 ; 52 Week High: $9.69 ; 52 Week Low: $1.84.

The stock opens at $2.04, after a previous close of $2.02. The stock reached a daily high of $2.04 and a low of $1.88, with a 52-week high of $9.69 and a 52-week low of $1.84.

Can Indians buy Tscan Therapeutics shares?

Yes, Indians can invest in the Tscan Therapeutics (TCRX) from India.

With INDmoney, you can buy Tscan Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Tscan Therapeutics at zero transaction cost.

How can I buy Tscan Therapeutics shares from India?

It is very easy to buy Tscan Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Tscan Therapeutics (TCRX) be purchased?

Yes, you can buy fractional shares of Tscan Therapeutics with INDmoney app.

What are the documents required to start investing in Tscan Therapeutics stocks?

To start investing in Tscan Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Tscan Therapeutics Stock (TCRX)?

Today’s highest price of Tscan Therapeutics (TCRX) is $2.04.

Today’s lowest price of Tscan Therapeutics (TCRX) is $1.88.

What is today's market capitalisation of Tscan Therapeutics?

Today's market capitalisation of Tscan Therapeutics TCRX is 104.3M

What is the 52 Week High and Low Range of Tscan Therapeutics Stock (TCRX)?

  • 52 Week High

    $9.69

  • 52 Week Low

    $1.84

What are the historical returns of Tscan Therapeutics (TCRX)?

  • 1 Month Returns

    -16.87%

  • 3 Months Returns

    -64.12%

  • 1 Year Returns

    -71.75%

  • 5 Years Returns

    -80.76%

Who is the Chief Executive Officer (CEO) of Tscan Therapeutics ?

Dr. Gavin MacBeath Ph.D. is the current Chief Executive Officer (CEO) of Tscan Therapeutics.